Building the Future of Transdermal Drug Delivery
Founded in Australia, LORAI Health is developing next generation transdermal technologies designed to improve treatment continuity, patient experience, and long-term health outcomes.
What began as a response to ongoing challenges in menopausal hormone therapy has evolved into a broader mission: advancing the future of transdermal medicines through innovation, manufacturing resilience, and patient-centred design.
A Drug Delivery Platform Ready for Innovation
Millions of people worldwide rely on transdermal medicines for the delivery of hormones, pain therapies, neurological treatments, and other essential medicines.
Yet many transdermal systems currenlty face challenges that include:
Manufacturing constraints
Supply vulnerabilities
Poor adhesion
Skin irritation
Inconsistent real-world performance
Patient discontinuation
Despite decades of clinical use, innovation across this category of drug delivery has been limited.
LORAI Health believes the next generation of transdermal therapies should deliver more than medicine. They should deliver reliability, continuity, comfort, and confidence.
Next Generation Transdermal Technologies
Advanced
Delivery
Designed to support reliable and consistent medicine delivery in real-world conditions.
Patient
Experience
Focus on comfort, wearability, skin compatibility, and treatment continuity.
Manufacturing Innovation
Exploring pathways to strengthen supply resilience and support future scalability.
Australian Origins.
Global Operations.
LORAI Health is building an international health technology company from Australia, working with partners across research, manufacturing, healthcare, and investment.
Our vision is to shape the future of transdermal medicines through technologies that can support patients and healthcare systems worldwide.
Innovation Through Collaboration
Investors
Supporting the development of scalable technologies within a growing global healthcare market.
Industry
Exploring opportunities across manufacturing, research, commercialisation, and supply chain innovation.
Healthcare
Engaging clinicians, researchers, and patient advocates to inform development.
Patients
Ensuring real-world patient experiences remain central to innovation.
